Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Variation in the CYP19A1 gene and risk of colon and rectal cancer.

Cancer causes & control : CCC - 1 Jul 2011

Slattery Martha L, Lundgreen Abbie, Herrick Jennifer S, Kadlubar Susan, Caan Bette J, Potter John D, Wolff Roger K

Abstract excerpt

CYP19A1, or aromatase, influences estrogen-metabolizing enzymes and may influence cancer risk. We examine variation in the CYP19A1 gene and risk of colorectal cancer using data from population-based case-control studies (colon n = 1,574 cases, 1,970 controls; rectal n = 791 cases, 999 controls). Four SNPs were statistically significantly associated with colon cancer and four were associated with rectal cancer....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Aromatase
Share to Carcinoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Colonic Neoplasms

Share to Estrogens

Share to Inflammation

Share to Rectal Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 21479914
DOI: 10.1007/s10552-011-9768-x
PMCID: PMC3225228

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Variation in the CYP19A1 gene and risk of colon and rectal cancer.PMID 21479914Read ↗

CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk.Semantic proximity Read ↗

COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations.Semantic proximity Read ↗

Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways.Semantic proximity Read ↗

Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk.Semantic proximity Read ↗

Estrogen and progesterone-related gene variants and colorectal cancer risk in women.Semantic proximity Read ↗

Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk.Semantic proximity Read ↗

Association study between CYP24A1 gene polymorphisms and cancer risk.Semantic proximity Read ↗

Polymorphisms in the CYP19A1 (aromatase) gene and endometrial cancer risk in Chinese women.Semantic proximity Read ↗

Genetic variation in bone morphogenetic protein and colon and rectal cancer.Semantic proximity Read ↗

Associations between CYP19A1 polymorphisms, Native American ancestry, and breast cancer risk and mortality: the Breast Cancer Health Disparities Study.Semantic proximity Read ↗

Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants.Semantic proximity Read ↗

Genetic variation in CYP19A1 and risk of breast cancer and fibrocystic breast conditions among women in Shanghai, China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.